| Symbol | ABUS |
|---|---|
| Name | ARBUTUS BIOPHARMA CORP |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 701 VETERANS CIRCLE, WARMINSTER, PA 18974 |
| Telephone | 604-419-3200 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001447028 |
| Description | None |
(99% Neutral) ARBUTUS BIOPHARMA CORP (ABUS) Announces Business Combination
Read moreArbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders
Read moreDirector Sawhney Roger 🟢 acquired 78.8K shares (1 derivative) of Arbutus Biopharma Corp (ABUS) at $4.24 Transaction Date: Jun 08, 2026 | Filing ID: 000040
Read moreDirector Beardsley Robert A 🟢 acquired 78.8K shares (1 derivative) of Arbutus Biopharma Corp (ABUS) at $4.24 Transaction Date: Jun 08, 2026 | Filing ID: 000039
Read moreNew Form S-8 - Arbutus Biopharma Corp <b>Filed:</b> 2026-06-05 <b>AccNo:</b> 0001447028-26-000027 <b>Size:</b> 265 KB
Read moreNew Form SCHEDULE 13G/A - Arbutus Biopharma Corp <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001011438-26-000347 <b>Size:</b> 11 KB
Read more(30% Negative) ARBUTUS BIOPHARMA CORP (ABUS) Reports Q2 2026 Financial Results
Read moreArbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
Read moreNew Form SCHEDULE 13D/A - Arbutus Biopharma Corp <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0000921895-26-001101 <b>Size:</b> 22 KB
Read more